When was Therapy Acceleration Program (TAP) founded?

Therapy Acceleration Program (TAP) was founded in 2007.

Where is Therapy Acceleration Program (TAP) headquartered?

Therapy Acceleration Program (TAP) is headquartered in Washington, DC.

What is Therapy Acceleration Program (TAP)'s total asset value?

Therapy Acceleration Program (TAP) has around in total assets under management.

How many investments has Therapy Acceleration Program (TAP) made?

Therapy Acceleration Program (TAP) has made 38 investments.

What has Therapy Acceleration Program (TAP) invested in?

Therapy Acceleration Program (TAP) has made numerous investments in companies like AvenCell , Allotera Therapeutics , and Crossbow Therapeutics within the Drug Discovery industry.

What has Therapy Acceleration Program (TAP) invested in recently?

Therapy Acceleration Program (TAP)'s latest investment was on 17-Sep-2026 in AvenCell , a company within the Drug Discovery industry.

Therapy Acceleration Program (TAP) investment portfolio

Therapy Acceleration Program (TAP) Overview

Investor Type

Venture Capital

Status

Active

Professionals

5

Investments

38

Portfolio

16

Exits

13

Therapy Acceleration Program (TAP) General Information

Company Description

Founded in 2007, Therapy Acceleration Program (TAP) is the venture philanthropy initiative of Blood Cancer United (formerly The Leukemia & Lymphoma Society). The firm seeks to invest in biotech companies developing innovative therapeutics for blood cancer patients

Business Details

Website

bloodcancerunited.org/tap

Year Founded

2007

Investor Status

Actively Seeking New Investments

Primary Investor Type

Not-For-Profit Venture Capital

Corporate Office

1201 15th Street North West
Suite 410
Washington, DC 20005
United States

Therapy Acceleration Program (TAP) Investments (38)

Company Name	Deal Date	Deal Type	Industry	Company Stage
AvenCell	17-Sep-2026	Later Stage VC	Drug Discovery	Clinical Trials - Phase 2
Allotera Therapeutics	08-Jul-2026		Drug Discovery	Clinical Trials - Phase 2
Crossbow Therapeutics	01-Mar-2026		Drug Discovery	Generating Revenue
Auron Therapeutics	23-Dec-2025		Drug Discovery	Generating Revenue
Enterome	12-Jun-2025		Drug Discovery	Clinical Trials - Phase 2
Solu Therapeutics	09-Apr-2025		Drug Discovery	Clinical Trials - Phase 1
ViTToria Biotherapeutics	12-Nov-2024		Drug Discovery	Clinical Trials - Phase 1
Enterome	30-Oct-2023		Drug Discovery	Clinical Trials - Phase 2
Enterome	25-Oct-2023	Later Stage VC	Drug Discovery	Clinical Trials - Phase 2
Dimericon Therapeutics	01-May-2023	Seed Round	Biotechnology	Startup

You’re viewing 10 of 38 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therapy Acceleration Program (TAP) Exits (13)

Company Name	Exit Date	Exit Type
OncoPep	04-Jun-2026	Out of Business
Immunitas Therapeutics	12-May-2026
ImCheck Therapeutics	15-Dec-2025
Abintus Bio	15-Jul-2025
Kymera Therapeutics	05-Jan-2024
Caribou Biosciences	14-Jul-2023
Carisma Therapeutics	07-Mar-2023
Protocol First	16-Dec-2021
Selvita	16-Oct-2019	IPO
Forty Seven	28-Jun-2018	IPO

You’re viewing 10 of 13 exits. Get the full list »

Therapy Acceleration Program (TAP) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.